Detalhe da pesquisa
1.
CD4+ T cell activation distinguishes response to anti-PD-L1+anti-CTLA4 therapy from anti-PD-L1 monotherapy.
Immunity
; 57(3): 541-558.e7, 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38442708
2.
Single-cell molecular profiling using ex vivo functional readouts fuels precision oncology in glioblastoma.
Cell Mol Life Sci
; 80(6): 147, 2023 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37171617
3.
The prognostic effect of radiological extranodal extension in HPV-positive oropharyngeal squamous cell carcinomas: a retrospective cohort analysis.
Eur Arch Otorhinolaryngol
; 281(3): 1541-1558, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38170212
4.
[18F] MFBG PET imaging: biodistribution, pharmacokinetics, and comparison with [123I] MIBG in neural crest tumour patients.
Eur J Nucl Med Mol Imaging
; 50(4): 1134-1145, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36435928
5.
Overall survival improvement in patients with metastatic clear-cell renal cell carcinoma between 2000 and 2020: a retrospective cohort study.
Acta Oncol
; 61(1): 22-29, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34711121
6.
Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study.
Lancet Oncol
; 22(6): 813-823, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34000245
7.
Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations.
Acta Neuropathol
; 141(6): 945-957, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33740099
8.
Lomustine and Bevacizumab in Progressive Glioblastoma.
N Engl J Med
; 377(20): 1954-1963, 2017 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-29141164
9.
Influence of pretreatment with everolimus or sunitinib on the subacute hematotoxicity of 177Lu-DOTATATE PRRT.
Acta Oncol
; 59(6): 644-651, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32036716
10.
Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study.
Lancet
; 390(10103): 1645-1653, 2017 Oct 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28801186
11.
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.
Lancet Oncol
; 17(11): 1521-1532, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27686946
12.
Phase Ib study of duligotuzumab (MEHD7945A) plus cisplatin/5-fluorouracil or carboplatin/paclitaxel for first-line treatment of recurrent/metastatic squamous cell carcinoma of the head and neck.
Cancer
; 122(24): 3803-3811, 2016 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27525588
13.
Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial.
Lancet Oncol
; 16(5): 583-94, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25892145
14.
Individualized dosimetry-based activity reduction of 9°Y-DOTATOC prevents severe and rapid kidney function deterioration from peptide receptor radionuclide therapy.
Eur J Nucl Med Mol Imaging
; 41(6): 1141-57, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24668274
15.
Cilengitide treatment of newly diagnosed glioblastoma patients does not alter patterns of progression.
J Neurooncol
; 117(1): 141-5, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24442484
16.
Detection of delirium in palliative care unit patients: a prospective descriptive study of the Delirium Observation Screening Scale administered by bedside nurses.
Palliat Med
; 28(1): 79-86, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23744840
17.
Exploring long-term responses to immune checkpoint inhibitors in recurrent and metastatic head and neck squamous cell carcinoma.
Oral Oncol
; 149: 106664, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38113661
18.
Molecular analysis using SalvGlandDx improves risk of malignancy estimation and diagnosis of salivary gland cytopathology: An exploratory multicenter study.
Cancer Cytopathol
; 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38563876
19.
Epigenetic landscape reorganization and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytoma.
bioRxiv
; 2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38562747
20.
Thrombocytopenia limits the feasibility of salvage lomustine chemotherapy in recurrent glioblastoma: a secondary analysis of EORTC 26101.
Eur J Cancer
; 178: 13-22, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36379185